Lingbao Gold (03330) issued 2.0191 million shares due to the conversion of convertible bonds.
Lingbao Gold (03330) announced that stockholders of convertible bonds can exercise their conversion rights to issue and distribute 201.91 million new shares, with a conversion price of HKD 17.83 per share, for a total conversion amount of HKD 36 million of outstanding convertible bonds.
Lingbao Gold (03330) announced that convertible bondholders have exercised their conversion rights and issued and distributed 2.0191 million new shares. The conversion price is HK$17.83 per share, converting the outstanding convertible bonds of HK$36 million.
Related Articles
Huiyu Pharmaceutical (688553.SH): Injection Carfizomib Obtained Drug Registration Certificate.
JINXUN RESOURCE (03636) announces expected comprehensive profit of approximately RMB 300 million to RMB 330 million for the year 2025.
7ROAD (00797) announces a profitable year with an estimated net profit attributable to shareholders of approximately 37 million yuan in the year 2025.
Huiyu Pharmaceutical (688553.SH): Injection Carfizomib Obtained Drug Registration Certificate.
JINXUN RESOURCE (03636) announces expected comprehensive profit of approximately RMB 300 million to RMB 330 million for the year 2025.
7ROAD (00797) announces a profitable year with an estimated net profit attributable to shareholders of approximately 37 million yuan in the year 2025.
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
